Emergency oxygen kit provider OxySure Therapeutics (OTCQB: OXYS) has agreed a supply deal.
The deal is with Essendant (NASDAQ:ESND), a global distributor of workplace essentials with $5.4 billion in sales, subsidiary ORS Nasco.
Julian T. Ross, chief executive of OxySure, said: “This agreement allows us to offer additional, complimentary offerings to our institutional customers seeking a single source solution for their medical emergency preparedness, therapeutics and medical risk management needs.”
The deal will allow the firm to sell its other first aid safety, respiratory protection, heat stress protection and eye protection kits, as well as its OxySure Model 615.
OxySure plans to develop products including, antiseptics, CPR masks, disposable and escape respirators and hydration and cooling items.
Clark Hood, VP of Sales for OxySure, added: “We remain committed to developing and selling innovative, patented products in the medical device and therapeutics areas.”